| josephface6's Forum Info |
| Joined: |
12-15-2024 |
| Last Visit: |
(Hidden) |
| Total Posts: |
0 (0 posts per day | 0 percent of total posts) |
| Total Threads: |
0 (0 threads per day | 0 percent of total threads) |
| Time Spent Online: |
(Hidden) |
| Members Referred: |
0 |
| Reputation: |
0
[Details] |
|
|
| Additional Info About josephface6 |
| Bio: |
177Lu-DOTATATE Plus Radiosensitizing Capecitabine Compared to Octreotide Long-Acting Relieve as First-Line Wide spread Remedy within Innovative Quality A couple of Gastroenteropancreatic Neuroendocrine Cancers: A new Single-Institution Experience.
https://www.selleckchem.com/mTOR.html |
| Gender: |
Other |
|